These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 115540)

  • 21. [Atrioventricular block in controlled hypotension induced by labetalol during general anesthesia].
    Bertrand D; Bollaert PE; Balaud A; Laxenaire MC
    Ann Fr Anesth Reanim; 1984; 3(4):325-7. PubMed ID: 6476508
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypertensive response to labetalol in phaeochromocytoma.
    Feek CM; Earnshaw PM
    Br Med J; 1980 Aug; 281(6236):387. PubMed ID: 7427286
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypertensive emergencies with oral labetalol.
    Ghose RR; Mathur YB; Upadhyay M; Morgan WD; Khan S
    Br Med J; 1978 Jul; 2(6130):96. PubMed ID: 667582
    [No Abstract]   [Full Text] [Related]  

  • 25. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical trial of labetalol (Tranedate) in general practice].
    Mathisen R; Sveen K
    Tidsskr Nor Laegeforen; 1983 Feb; 103(5):541-3. PubMed ID: 6223408
    [No Abstract]   [Full Text] [Related]  

  • 28. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
    Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
    Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term treatment of hypertension with labetalol.
    Prichard BN; Boakes AJ; Hernández R
    Br J Clin Pharmacol; 1979; 8(Suppl 2):171S-177S. PubMed ID: 526398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pressor response after intravenous labetalol.
    Crofton M; Gabriel R
    Br Med J; 1977 Sep; 2(6089):737. PubMed ID: 912276
    [No Abstract]   [Full Text] [Related]  

  • 32. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scalp tingling and difficulty in micturition in patients on labetalol.
    Bailey RR
    Lancet; 1977 Oct; 2(8040):720-1. PubMed ID: 71532
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labetalol and phaeochromocytoma.
    Navaratnarajah M; White DC
    Br J Anaesth; 1984 Oct; 56(10):1179. PubMed ID: 6477797
    [No Abstract]   [Full Text] [Related]  

  • 36. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension.
    Immink RV; van den Born BJ; van Montfrans GA; Kim YS; Hollmann MW; van Lieshout JJ
    Hypertension; 2008 Aug; 52(2):236-40. PubMed ID: 18606905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 39. SLE syndrome, probably induced by labetalol.
    Brown RC; Cooke J; Losowsky MS
    Postgrad Med J; 1981 Mar; 57(665):189-90. PubMed ID: 6977135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupus-type illness associated with labetalol.
    Griffiths ID; Richardson J
    Br Med J; 1979 Aug; 2(6188):496-7. PubMed ID: 314829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.